Treatment of the Metabolic Syndrome in an Interdisciplinary Obesity Clinic: a Randomized Controlled Study
NCT ID: NCT01008878
Last Updated: 2009-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2004-03-31
2006-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We want to show the benefits of coherent interdisciplinary care in the obesity clinic of CHUS (Centre Hospitalier Universitaire de Sherbrooke) in comparison to the conventional treatment in order to:
* Improve subjects' characteristic features of metabolic syndrome: weight, waist circumference, fatty mass, plasma lipid profile, blood pressure, fasting glycaemia, and HbA1c;
* Improve our patients' nutritive practices;
* Decrease our patients' sedentary lifestyle;
* Improve our patients' motivation to lose weight, and to improve their quality of life; We also wish to define predictors of answer in order to better select the patients if necessary, and evaluate the costs incurred by the health system.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrated Obesity Care Management System
NCT01385397
Interdisciplinary Intervention in Patients With Obesity and Other Metabolic Diseases
NCT02573688
Impact of an Integrated Obesity Management System on Patient's Care
NCT00991640
Internet Treatment for Weight Loss in Primary Care
NCT01558297
Lifestyle Intervention in Obese Arab Women
NCT00273572
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The interdisciplinary treatment group received interventions at our clinic for 6 months.. The intervention included a visit every 6 weeks including a nursing consultation (listening, psychological support, anthropometric measurements and blood pressure), an endocrinologist consultation, a nutritionist consultation (initial evaluation of food intake and counselling), a psychologist consultation if needed, an interactive group information session (to discuss the following: diet, psychological aspects associated with obesity, physical education, complications and pharmacological treatments of obesity), and a questionnaire on the individual costs of their visit.
A control group was monitored during this 6 months by their family physician, as per usual.
A biological assessment, questionnaires, and tests will be carried out in beginning and end of program: the questionnaires are to evaluate the physical activity (Sallis, Canada fitness survey); the quality of life (IWQOL-Lite, SF-36); the motivation (analogical visual Scales); knowledge (pretest and post-test); and costs. Tests to assess physical activity (6-minute walk test and accelerometer) will also be administered.
After the first 6 months, both groups were followed at the obesity clinic for another 12 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
interdisciplinary intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \> 27 kg/m²; (Body Mass Index)
* metabolic associated syndrome according to the definition of the NCEP-ATP III
* be able to give an inform consent
Criteria Exclusion:
* Impossibility to be present at the visits
* Physical/motor incapacity (or other) making one unable and insecure to walk at a moderate to rapid speed for 6 min and more
* Use of an anti-obesity treatment the last 3 months
* Bariatric Surgery in the past
* Planned Pregnancy
* Pacemaker
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Université de Sherbrooke
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie-France Langlois, MD
Role: PRINCIPAL_INVESTIGATOR
Medecine Department, Division of endocrinology, CHUS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de Recherche Clinique (CRC), Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.